ACM

AIGH Capital Management Portfolio holdings

AUM $488M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+327.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$488M
AUM Growth
+$150M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1 +$24.3M
2 +$24.1M
3 +$23.5M
4
APPS icon
Digital Turbine
APPS
+$21M
5
GNRC icon
Generac Holdings
GNRC
+$17.3M

Top Sells

1 +$45.2M
2 +$18.6M
3 +$15.5M
4
BKTI icon
BK Technologies
BKTI
+$14.5M
5
LASR icon
nLIGHT
LASR
+$14.1M

Sector Composition

1 Technology 53.22%
2 Healthcare 39.99%
3 Industrials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELUT icon
26
Elutia
ELUT
$46M
$3.78M 0.77%
3,595,250
+527,065
RNXT icon
27
RenovoRx
RNXT
$41.1M
$3.68M 0.75%
3,706,197
+872,303
TLPH icon
28
Talphera
TLPH
$40.2M
$3.48M 0.71%
4,661,502
WATT icon
29
Energous
WATT
$172M
$3.37M 0.69%
+215,000
IPWR icon
30
Ideal Power
IPWR
$122M
$3.34M 0.68%
1,181,696
+689,707
NRXS icon
31
Neuraxis
NRXS
$86.8M
$2.96M 0.61%
400,000
BKTI icon
32
BK Technologies
BKTI
$310M
$2.43M 0.5%
32,615
-178,838
LPCN icon
33
Lipocine
LPCN
$18.5M
$1.6M 0.33%
+200,000
INVE icon
34
Identive
INVE
$100M
$1.51M 0.31%
+409,186
LPTH icon
35
Lightpath Technologies
LPTH
$1.01B
$1M 0.21%
100,000
-930,738
RGNT
36
Regentis Biomaterials
RGNT
$8.6M
$917K 0.19%
+300,000
APRE icon
37
Aprea Therapeutics
APRE
$9.46M
$775K 0.16%
1,015,541
+645,000
BFRI icon
38
Biofrontera
BFRI
$13.2M
$740K 0.15%
915,210
QNRX
39
Quoin Pharmaceuticals
QNRX
$9.16M
$337K 0.07%
51,000
+1,677
SMTK
40
SmartKem
SMTK
$6.3M
$204K 0.04%
895,449
+220,449
DAWN
41
DELISTED
Day One Biopharmaceuticals
DAWN
-1,992,021
DOMO icon
42
Domo
DOMO
$193M
-1,837,762
IWM icon
43
iShares Russell 2000 ETF
IWM
$79.7B
0
STX icon
44
Seagate
STX
$210B
0
XLK icon
45
State Street Technology Select Sector SPDR ETF
XLK
$129B
0
ARQ icon
46
Arq
ARQ
$117M
-2,273,092
ARDX icon
47
Ardelyx
ARDX
$1.36B
-1,150,000
BYRN icon
48
Byrna Technologies
BYRN
$141M
-394,906
ZM icon
49
Zoom
ZM
$32.8B
0
GRCE
50
Grace Therapeutics
GRCE
$38.7M
-907,217